Track and Trace Migration: Six make-or-break considerations

Many pharmaceutical manufacturers have learned that the system they initially implemented for compliance is no longer meeting their needs. They’re experiencing some very significant challenges:

• Constant EPCIS, serial number and aggregation errors delaying shipments
• Endless revalidations, buggy patches and custom code fixes
• Hidden costs piling up every quarter
• Unresponsive support when they need it most

Switching track and trace systems is a big decision. This comprehensive guide provides the insight you need to make an informed, low-risk change that positions your business for long-term success.

What’s in the guide

• Key considerations to help you transition to a new solution with minimal disruption
• Benchmark data highlighting the main reasons companies are switching track and trace solutions
• Clarifying questions, you need to ask any alternative track and trace provider you may be considering